In July, the U.S. Food and Drug Administration (FDA) approved Beyfortus™ (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants born during…
This multi-page pharmacy pearl provides guidance from the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) on bivalent COVID-19 vaccine use in adult and…
In this two-page edition of Pharmacy Pearls, we review the network-wide pharmacy savings opportunities identified by the AHP Pharmacy Team for 2023. There continue to be opportunities in several therapeutic…
The Highland Hospital Department of Pharmacy is hosting a Grand Rounds session on Wednesday, April 5, from 12 pm to 1 pm titled “Crossing Out Penicillin and Cephalosporin Cross-Reactivity.” The…
As our network’s practices and providers settle into the 2023 performance year, AHP would like to place renewed emphasis on the new PCP Reward Plan. To ensure that network providers…
Starting April 1, 2023, NYS Medicaid-enrolled patients will have a change in who is providing their prescription benefits. Currently, NYS Medicaid-enrolled patients access prescription benefits through a health plan, and the…
In this edition of Pharmacy Pearls, you will find a brief review of the management of gout, including dosing guidance for preferred agents for treating acute gout attacks and for…
In this edition of Pharmacy Pearls, we have compiled some of the key updates from the 2023 American Diabetes Association Standards of Medical Care in Diabetes. One major highlight is…
In an effort to assist providers in navigating shortages of Methylphenidate products, the AHP/URMC Pharmacy team is providing our network’s primary care providers with guidance on available alternatives, dosage recommendations,…
